secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fortress Biotech, Inc. (FBIO)
CIK:        0001429260
Form:       8-K
Filed at:   2024-01-03T23:59:59+00:00
Accession:  0001104659-24-000821
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fortress Biotech closes registered direct offering of 3.3M units at $3.33 for $11M gross proceeds
--------------------------------------------------------------------------------

- Offered 3,303,305 units at $3.33 each, each consisting of one share of common stock and one warrant.
- Warrants have exercise price of $3.21 per share, immediately exercisable, expiring five years from issuance.
- Gross proceeds approximately $11.0 million before placement agent fees and expenses.
- Net proceeds to be used for operations, including R&D, clinical trials, acquisitions, and working capital.
- Roth Capital Partners acted as exclusive placement agent with a 7% commission; offering closed on January 3, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1429260/000110465924000821/0001104659-24-000821-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1429260/000110465924000821/tm241522d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-000821

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer